C22 Sphingomyelin (d18:1/22:0) – 500 µg

Brand:
Cayman
CAS:
94359-12-3
Storage:
-20
UN-No:
Non-Hazardous - /

C22 Sphingomyelin is a naturally occurring form of sphingomyelin (Item Nos. 22674 | 24345). Plasma levels of C22 sphingomyelin positively correlate with hepatic steatosis severity in patients with chronic hepatitis C virus (HCV).{39540} C22 Sphingomyelin levels are decreased in T-47D mammary epithelial cells and increased in MDA-MB-231 breast cancer cells relative to C16 sphingomyelin (Item No. 10007946).{39539} [Matreya, LLC. Catalog No. 1918]  

 

Available on backorder

SKU: 24451 - 500 µg Category:

Description

A sphingolipid; plasma levels correlate with hepatic steatosis severity in HCV patients; decreases in T-47D mammary epithelial cells and increased in MDA-MB-231 breast cancer cells relative to C16 sphingomyelin


Formal name: (7S)-4-hydroxy-7-[(1R,2E)-1-hydroxy-2-hexadecen-1-yl]-N,N,N-trimethyl-9-oxo-3,5-dioxa-8-aza-4-phosphatriacontan-1-aminium, 4-oxide, inner salt

Synonyms:  N-docosanoyl-D-erythro-Sphingosylphosphorylcholine|SM(d18:1/22:0)|Sphingomyelin (d18:1/22:0)

Molecular weight: 787.2

CAS: 94359-12-3

Purity: ≥98%

Formulation: A solid


Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Cancer||Research Area|Endocrinology & Metabolism|Metabolic Diseases||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|Hepatitis||Research Area|Lipid Biochemistry|Sphingolipids